Advertisement

Topics

Gilead Receives Positive Opinion for Chronic Hepatitis C Treatments

10:49 EDT 23 Jun 2017 | PharmPro

European CHMP adopts positive opinion for Gilead’s Vosevio (sofosbuvir/velpatasvir/voxilaprevir) for the treatment of all chronic hepatitis C genotypes.
Contributed Author: 
Gilead Sciences, Inc.

Original Article: Gilead Receives Positive Opinion for Chronic Hepatitis C Treatments

NEXT ARTICLE

More From BioPortfolio on "Gilead Receives Positive Opinion for Chronic Hepatitis C Treatments"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...